Company intelligence / Profile preview

Clinical Enrollment

Ownership: Private
Development stage: Other

Overview

Clinical Enrollment’s services have led to an average of 57 days faster enrollment, a 4.4x increase in recruitment speed, 18% reduction in screen fail rates, and 32% representation of under-represented populations in trials. It provides services to drug sponsors and biotech companies to accelerate and improve patient enrollment in clinical trials across phases.

Therapeutic areas: ImmunologyOphthalmologyNeurologyRare DiseasesOtherDermatologyOncology
Industry: Contract Research Organization

Partnerships

Major biotech and pharma clients as sponsors (specific names not listed)

Beyond the preview

Go deeper on Clinical Enrollment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinical Enrollment.

Explore the full profile